In the in vivo study, tumor volume in the mice implanted with EGFRvIII+ and IL-13Rα2+ glioma cells increased significantly in comparison with the mice implanted with WT epidermal growth factor receptor (EGFR) glioma cells. This evidence concerns the gene IL13RA2 and neoplasm.